PrimeVigilance looks forward to attending the upcoming World Drug Safety Congress Europe 2024 that will take place in Amsterdam, The Netherlands from 9-10 October.
The World Drug Safety Congress Europe 2024, taking place from 9–10 October 2024 in Amsterdam, is a premier event for professionals in drug safety and pharmacovigilance. With a strong tradition of delivering cutting-edge content, the congress focuses on innovations and best practices in drug safety, compliance, and regulatory affairs.
If you’re attending, be sure to visit PrimeVigilance’s Booth #99. Our team of experts will be available to discuss how our full suite of drug safety and pharmacovigilance services can help you navigate complex regulatory frameworks and optimize patient safety strategies. From risk management and regulatory compliance to comprehensive pharmacovigilance services, we are committed to supporting you in every aspect of drug safety.
PrimeVigilance Expert Session
Don’t miss the opportunity to hear from Nikodem Latocha, Associate Director of Computerised Systems Quality at PrimeVigilance, who will be speaking on October 10 at 15:45 on the topic of “The Regulatory Landscape of AI: The Current State and Future Trends“. His session will delve into the role of AI and automation in pharmacovigilance, providing insights on how these cutting-edge technologies can enhance efficiency, accuracy, and compliance in drug safety processes.
Meet our Experts at #WDSCEurope24!
Sally Amanuel
President, PrimeVigilance
Valerie Leray
Senior Vice President, Global Head of Project Management and Strategic Partnerships
Sanja Pavlovic
Senior Regulatory Affairs Manager
Elena Alcaraz Garcia
Strategic Advisor
Joakim Lindroos
Senior Vice President of Marketing
Barbara Busic
Director of Marketing
Joe Pierce
Senior Vice President of Business Development
Alessandro Di Ranno
Vice President of Business Development
Olivija Sileike
Director of Business Development
Jan Mueller
Director of Business Development
Rada Gantly
Director of Business Development